Skip to main content

Table 4 Community’s perceptions of side effects and benefits of IRS with VECTRON T500 and Actellic® 300CS

From: Long-lasting residual efficacy of a new indoor residual spraying product, VECTRON T500 (broflanilide), against pyrethroid-resistant malaria vectors and its acceptance in a community trial in Burkina Faso

Perceived adverse events and benefits of IRS

VECTRON T500 sprayed site N (%)

Actellic® 300CS sprayed site N (%)

Unpleasant smell

0 (0)

0 (0)

Dizziness

0 (0)

0 (0)

Running nose

0 (0)

0 (0)

Fever

0 (0)

0 (0)

Headache

0 (0)

0 (0)

Cold

0 (0)

1 (0.002)

Sore eyes

0 (0)

0 (0)

Skin irritation

0 (0)

0 (0)

Coughing

0 (0)

0 (0)

Vomiting

0 (0)

0 (0)

Sneezing

0 (0)

0 (0)

Sleeplessness

0 (0)

0 (0)

Was the IRS beneficial?

360 (100)

360 (100)

Did the use of the IRS reduced mosquito bites?

360 (100)

360 (100)

Would you continue IRS intervention?

360 (100)

360 (100)

  1. Thirty people were surveyed each month for 12 months after IRS applications